Other candidate proteins tested, such as FIBRONECTIN did not show a predicted change in expression with TMEM230 downregulation suggesting that additional genes influence glioma tumor formation and progression (Supplementary Figure 10C). This evidence concerns the gene TMEM230 and central nervous system cancer.